Clinical trial
Phase I Perifosine and Gemcitabine Study
NCT00398697 · AEterna Zentaris, Industry · Completed
Key facts
| NCT number | NCT00398697 |
|---|---|
| Title | Phase I Perifosine and Gemcitabine Study |
| Official title | Phase 1 Trial of the Combination of Perifosine and Gemcitabine |
| Lead sponsor | AEterna Zentaris, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Neoplasms |
| Intervention type | Drug |
| Interventions | Perifosine, Gemcitabine |
| Enrollment | 19 |
| Start date | Aug 1, 2004 |
| Completion | Jan 1, 2006 |
| First posted | Nov 14, 2006 |
| Last update posted | Feb 13, 2014 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: